Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 44,945 | 647,513 | 6.9M | 3.8M |
| Operating Revenue | 44,945 | 647,513 | 6.9M | 3.8M |
| Cost Of Revenue | 163,499 | 349,818 | 917,365 | 1.1M |
| Gross Profit | -118,554 | 297,695 | 6.0M | 2.7M |
| Selling General And Administration | 1.6M | 2.9M | 3.5M | 3.2M |
| General And Administrative Expense | 1.5M | 2.8M | 3.2M | 2.9M |
| Other Operating Expenses | 537,944 | 617,023 | 203,117 | 187,247 |
| Operating Expense | 2.1M | 3.5M | 3.7M | 3.3M |
| Operating Income | -2.2M | -3.2M | 2.4M | -632,289 |
| EBIT | -2.2M | -3.2M | 2.4M | -632,289 |
| Interest Income | 703,585 | 682,896 | 206,523 | 17,026 |
| Interest Income Non Operating | 703,585 | 682,896 | 206,523 | 17,026 |
| Net Interest Income | 999,136 | 973,060 | 529,963 | 296,862 |
| Other Income Expense | 3.1M | -720,696 | 537,722 | 12.5M |
| Other Non Operating Income Expenses | 1.2M | 538,975 | -26,219 | -143,909 |
| Special Income Charges | 577,339 | -892,775 | -96,520 | 13.1M |
| Gain On Sale Of Security | 1.3M | -366,896 | 660,461 | -464,805 |
| Earnings From Equity Interest | -9,444 | 0.00 | -- | -- |
| Pretax Income | 1.8M | -3.0M | 3.4M | 12.1M |
| Tax Provision | -181,374 | -24,594 | 199,161 | 92,663 |
| Tax Effect Of Unusual Items | 279,679 | -10,433 | 32,847 | 96,324 |
| Net Income From Continuing And Discontinued Operation | 2.0M | -2.9M | 3.2M | 12.0M |
| Net Income From Continuing Operation Net Minority Interest | 2.0M | -2.9M | 3.2M | 12.0M |
| Net Income Including Noncontrolling Interests | 2.0M | -2.9M | 3.2M | 12.0M |
| Net Income Common Stockholders | 2.0M | -2.9M | 3.2M | 12.0M |
| Net Income | 2.0M | -2.9M | 3.2M | 12.0M |
| EBITDA | -2.1M | -3.0M | 2.6M | -423,793 |
| Normalized EBITDA | -3.9M | -1.7M | 2.0M | -13.0M |
| Reconciled Depreciation | 163,499 | 257,321 | 228,005 | 208,496 |
| Basic EPS | 0.03 | -0.05 | 0.06 | 0.19 |
| Diluted EPS | 0.03 | -0.05 | 0.06 | 0.19 |
| Basic Average Shares | 61.0M | 60.9M | 60.6M | 60.6M |
| Diluted Average Shares | 61.0M | 60.9M | 61.0M | 64.9M |
| Total Unusual Items | 1.9M | -1.3M | 563,941 | 12.6M |
| Total Unusual Items Excluding Goodwill | 1.9M | -1.3M | 563,941 | 12.6M |
| Tax Rate For Calcs | 0.15 | 0.01 | 0.06 | 0.01 |
| Normalized Income | 416,346 | -1.7M | 2.7M | -475,675 |
| Diluted NI Availto Com Stockholders | 2.0M | -2.9M | 3.2M | 12.0M |
| Gain On Sale Of Ppe | 387,264 | 109,994 | 23,960 | 13.6M |
| Impairment Of Capital Assets | 182,866 | 1.0M | 120,480 | 545,060 |
| Net Income Continuous Operations | 2.0M | -2.9M | 3.2M | 12.0M |
| Net Non Operating Interest Income Expense | 999,136 | 973,060 | 529,963 | 296,862 |
| Other Gand A | 1.5M | 1.7M | 1.6M | 1.6M |
| Other Special Charges | -372,941 | -- | -- | -- |
| Reconciled Cost Of Revenue | 163,499 | 349,818 | 917,365 | 1.1M |
| Salaries And Wages | 1,750 | 1.0M | 1.6M | 1.3M |
| Selling And Marketing Expense | 107,918 | 146,539 | 285,327 | 233,293 |
| Total Expenses | 2.3M | 3.9M | 4.6M | 4.4M |
| Total Operating Income As Reported | -- | -- | -- | -335,427 |
| Total Other Finance Cost | -295,551 | -290,164 | -323,440 | -279,836 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 12.9M | 16.2M | 18.4M | 17.2M |
| Cash Cash Equivalents And Short Term Investments | 13.9M | 17.3M | 19.5M | 19.0M |
| Cash Equivalents | -- | 13.5M | 12.8M | 13.3M |
| Cash Financial | -- | 2.7M | 5.6M | 3.9M |
| Other Short Term Investments | 1.0M | 1.1M | 1.1M | 1.8M |
| Accounts Receivable | 160,818 | 121,088 | 561,844 | 705,783 |
| Receivables | 160,818 | 121,088 | 561,844 | 705,783 |
| Prepaid Assets | 72,636 | 34,465 | 96,862 | 49,503 |
| Current Assets | 14.2M | 17.5M | 20.1M | 19.8M |
| Gross PPE | 6.5M | 4.2M | 3.9M | 1.9M |
| Accumulated Depreciation | -1.1M | -1.2M | -898,731 | -709,747 |
| Net PPE | 5.4M | 3.0M | 3.0M | 1.2M |
| Investments And Advances | 219,717 | 0.00 | -- | -- |
| Long Term Equity Investment | 219,717 | 0.00 | -- | -- |
| Other Non Current Assets | 139,223 | 75,215 | 40,000 | -- |
| Total Non Current Assets | 14.0M | 8.9M | 8.3M | 6.1M |
| Total Assets | 28.2M | 26.4M | 28.4M | 25.9M |
| Accounts Payable | 395,422 | 590,335 | 443,567 | 493,920 |
| Payables | 395,422 | 590,335 | 443,567 | 1.2M |
| Payables And Accrued Expenses | 395,422 | 590,335 | 443,567 | 1.2M |
| Current Liabilities | 395,422 | 590,335 | 443,567 | 1.2M |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 395,422 | 590,335 | 443,567 | 1.2M |
| Common Stock | 23.6M | 23.6M | 23.3M | 23.3M |
| Capital Stock | 23.6M | 23.6M | 23.3M | 23.3M |
| Retained Earnings | 1.8M | -230,726 | 2.7M | -505,974 |
| Gains Losses Not Affecting Retained Earnings | -- | -- | -- | 1.9M |
| Common Stock Equity | 27.8M | 25.8M | 28.0M | 24.7M |
| Stockholders Equity | 27.8M | 25.8M | 28.0M | 24.7M |
| Total Equity Gross Minority Interest | 27.8M | 25.8M | 28.0M | 24.7M |
| Total Capitalization | 27.8M | 25.8M | 28.0M | 24.7M |
| Net Tangible Assets | 27.8M | 25.8M | 28.0M | 24.7M |
| Tangible Book Value | 27.8M | 25.8M | 28.0M | 24.7M |
| Working Capital | 13.8M | 16.9M | 19.7M | 18.6M |
| Invested Capital | 27.8M | 25.8M | 28.0M | 24.7M |
| Share Issued | 61.0M | 61.0M | 60.7M | 60.6M |
| Ordinary Shares Number | 61.0M | 61.0M | 60.7M | 60.6M |
| Income Tax Payable | -- | -- | 0.00 | 694,005 |
| Investmentsin Associatesat Cost | 219,717 | 0.00 | -- | -- |
| Machinery Furniture Equipment | 473,826 | 685,333 | 681,328 | 436,699 |
| Non Current Accounts Receivable | -- | -- | -- | 15,600 |
| Non Current Deferred Assets | 160,266 | 180,275 | 380,582 | 601,342 |
| Non Current Deferred Taxes Assets | 160,266 | 180,275 | 380,582 | 601,342 |
| Non Current Note Receivables | 8.1M | 5.7M | 4.9M | 4.3M |
| Other Equity Interest | 2.5M | 2.5M | 2.0M | 1.9M |
| Other Properties | 137,473 | 100,877 | 97,797 | 97,797 |
| Total Tax Payable | -- | -- | 0.00 | 694,005 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -360,479 | -873,505 | 3.4M | 222,521 |
| Cash Flow From Continuing Operating Activities | -360,479 | -873,505 | 3.4M | 222,521 |
| Depreciation And Amortization | 163,499 | 257,321 | 228,005 | 208,496 |
| Depreciation Amortization Depletion | 163,499 | 257,321 | 228,005 | 208,496 |
| Stock Based Compensation | 1,750 | 788,272 | 56,000 | 615,456 |
| Deferred Tax | -181,374 | -24,594 | 199,161 | 92,663 |
| Deferred Income Tax | -181,374 | -24,594 | 199,161 | 92,663 |
| Change In Working Capital | -42,851 | 832,854 | -607,515 | 148,304 |
| Changes In Account Receivables | 123,482 | 692,497 | 118,179 | -159,359 |
| Change In Receivables | 123,482 | 692,497 | 118,179 | -159,359 |
| Change In Payables And Accrued Expense | -166,333 | 140,357 | -725,694 | 307,663 |
| Change In Payable | -166,333 | 140,357 | -725,694 | 307,663 |
| Other Non Cash Items | -1.9M | -829,139 | -281,621 | -135,927 |
| Capital Expenditure | -108,206 | -7,085 | -452,224 | -161,016 |
| Purchase Of PPE | -108,206 | -7,085 | -452,224 | -161,016 |
| Net PPE Purchase And Sale | -22,017 | -7,085 | -406,438 | -150,534 |
| Purchase Of Business | -155,161 | -- | -- | -- |
| Sale Of Investment | -- | -- | 0.00 | 15,230 |
| Net Investment Purchase And Sale | -- | -- | 0.00 | 15,230 |
| Investing Cash Flow | -3.0M | -1.3M | -2.2M | 11.8M |
| Cash Flow From Continuing Investing Activities | -3.0M | -1.3M | -2.2M | 11.8M |
| Issuance Of Capital Stock | -- | -- | -- | 0.00 |
| Net Common Stock Issuance | -- | -- | -- | 0.00 |
| Financing Cash Flow | 0.00 | -41,747 | -10,125 | 0.00 |
| Cash Flow From Continuing Financing Activities | 0.00 | -41,747 | -10,125 | 0.00 |
| Changes In Cash | -3.3M | -2.2M | 1.2M | 12.0M |
| Beginning Cash Position | 16.2M | 18.4M | 17.2M | 5.2M |
| End Cash Position | 12.9M | 16.2M | 18.4M | 17.2M |
| Free Cash Flow | -468,685 | -880,590 | 2.9M | 61,505 |
| Asset Impairment Charge | 182,866 | 1.0M | 120,480 | 545,060 |
| Common Stock Issuance | -- | -- | -- | 0.00 |
| Depreciation | 163,499 | 257,321 | 228,005 | 208,496 |
| Earnings Losses From Equity Investments | 9,444 | 0.00 | -- | -- |
| Gain Loss On Investment Securities | -- | -- | -- | 3,460 |
| Gain Loss On Sale Of PPE | -387,264 | -109,994 | -23,960 | -13.6M |
| Net Business Purchase And Sale | -155,161 | -- | -- | -- |
| Net Foreign Currency Exchange Gain Loss | -600,749 | 55,949 | -310,410 | 15,689 |
| Net Income From Continuing Operations | 2.0M | -2.9M | 3.2M | 12.0M |
| Net Intangibles Purchase And Sale | -- | -- | 0.00 | 12.7M |
| Net Other Financing Charges | -- | -41,747 | -14,875 | -- |
| Net Other Investing Changes | -2.8M | -1.2M | -1.8M | -815,613 |
| Operating Gains Losses | -978,569 | -54,045 | -334,370 | -13.6M |
| Proceeds From Stock Option Exercised | 0.00 | 0.00 | 4,750 | 0.00 |
| Sale Of Intangibles | -- | -- | 0.00 | 12.7M |
| Sale Of PPE | 86,189 | 0.00 | 45,786 | 10,482 |
| Unrealized Gain Loss On Investment Securities | 361,405 | 97,954 | 758,688 | 311,184 |